Stelios Papadopoulos - BG Medicine Insider

BGMD -- USA Stock  

USD 0.021  0.009  30.00%

  Director
Dr. Stelios B. Papadopoulos, Ph.D., is an Independent Director of BG Medicine, Inc. He has served as Chairman of Fondation Sant, a private charitable foundation whose mission is to provide support for research and education in the life sciences. Dr. Papadopoulos served as Vice Chairman of Cowen and Company, LLC from 2003 until 2006 and as Managing Director from 2000 until 2003. While at Cowen and Company, LLC, he worked as an investment banker focused on the biotech and pharmaceutical sectors. Prior to joining Cowen and Company, LLC, he worked as an investment banker at PaineWebber, Incorporated, from 1987 to 2000, where he was Chairman of PaineWebber Development Corporationration, a PaineWebber subsidiary focusing on biotechnology from 1996 to 2000. Dr. Papadopoulos is a cofounder and Chairman of the Board of Exelixis, Inc. Dr. Papadopoulos currently serves as chairman of the board of Regulus Therapeutics, Inc. and Biogen Inc. and he is a member of the board of directors of Joule Unlimited, Inc. During the past five years, he also served on the board of directors of Anadys Pharmaceuticals, Inc., and Cellzome, Inc. . He is also a member of the board of visitors of Duke University School of Medicine and the board of Global Advisors of the Duke Institute of Health Innovation
Age: 68  Director Since 2012  MBA    
781-890-1199  http://www.bg-medicine.com
Papadopoulos holds a Ph.D. in biophysics and an M.B.A. in finance, both from New York University.

Stelios Papadopoulos Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (75.95) % which means that it has lost $75.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (902.64) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives

DIRECTOR Since

Roy WhitfieldIllumina
2007
JeanPaul MangeolleCharles River Laboratories Inte
2018
Matthew NortonMedpace Holdings
2015
George MassaroCharles River Laboratories Inte
2003
Cornelius McCarthyMedpace Holdings
2018
Colin HillBioTelemetry
2016
Stephen ChubbCharles River Laboratories Inte
1994
Edward DriscollNatera
2007
George ScangosAgilent Technologies
2014
Brian CarleyMedpace Holdings
2016
Joseph FrickBioTelemetry
2013
John ThompsonIllumina
2017
Michael WyzgaExact Sciences Corporation
2015
Daniel BradburyIllumina
2004
Savita AcharyaNational Research Corporation
2015
Gail MarcusNatera
2017
Richard ReeseCharles River Laboratories Inte
2007
James HealyNatera
2014
Sally CrawfordExact Sciences Corporation
2008
Robert KraftMedpace Holdings
2016
Katherine NapierExact Sciences Corporation
2009

Entity Summary

BG Medicine, Inc. engages in development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts. BG Medicine operates under Diagnostics Research classification in USA and traded on OTC Market. It employs 5 people.BG Medicine (BGMD) is traded on OTC Market in USA. It is located in 303 Wyman Street and employs 5 people.

BG Medicine Leadership Team

James Connor, Director
Harry Wilcox, Director
Stelios Papadopoulos, Independent Director
Aram Adourian, Chief Scientific Officer and Sr. VP
Stephen Hall, CFO, Principal Accounting Officer, Executive VP and Treasurer
Jeffrey Luber, Director
Paul Sohmer, President CEO, Director
Noubar Afeyan, Founder
James OConnor, Independent Director

Stock Performance Indicators

Current Sentiment - BGMD

BG Medicine Investor Sentiment

Most of Macroaxis users are currently bullish on BG Medicine. What is your opinion about investing in BG Medicine? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

BG Medicine Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for BG Medicine and Illumina. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com